The size of the mammography market in Europe was valued at USD 484.86 million in 2023. This value is expected to reach USD 641.84 million by the end of 2028, with a CAGR of 5.77% during the forecast period.
The growing patient population suffering from breast cancer in the European region is majorly propelling the European mammography market growth. As per the data published by The European Breast Cancer Coalition, an estimated 1 in 11 women are likely to develop breast cancer before age 74 in EU-27 and an estimated 355,500 breast cancer cases were recorded in 2020 in EU-27. Furthermore, the growing number of female employees in the European region and an increasing number of breast cancer awareness programs for employed women at their working organizations are favoring the Europe mammography market growth.
In addition, the growing awareness about the mammography benefits among the European population is contributing to the European mammography market growth. As per recent reports, mammography screening programs in Europe help reduce breast cancer mortality rate by about 30 percent in women aged between 50- 75. Therefore, the government in this region decided to conduct several awareness programs in every area to inform the women population of mammogram screening, which helps increase the quality of life. In addition, they also provide video-based and paper-based information to clearly understand breast cancer symptoms and the procedure for every uneducated and educated woman.
The rapid adoption of technological advancements in mammography tests is further fuelling the growth rate of the European market. The key market players and manufacturers are focusing on the development of advanced devices for mammography. In addition, image quality plays a significant role in mammography testing. Therefore, manufacturers are focused on providing high-quality mammography equipment at an affordable cost for the hospital and diagnostic centers. The growing R&D activities around mammography, increasing support from the European governments in favor of mammography and favorable reimbursement policies for mammography in the European region are supporting the growth rate of the European market.
The growing healthcare expenditure is another key factor favoring the mammography market growth in Europe. European Commission takes several measures in the prevention of breast cancer among the women population. It has recommended that women who are aged above 50 must undergo mammography testing, which reduces the breast cancer rate in the region. Increasing demand for mobile mammography in the region boosts market growth in Europe. This mobile mammography is well equipped with all the digital 3D technology to help to detect breast cancer in its early stage, helping the women complete mammography testing without leaving their workplace or community.
On the other hand, the side effects associated with mammography such as radiation is majorly hampering the European mammography market growth. In addition, inaccurate results from the test, lack of infrastructure in rural hospitals, and lack of awareness about mammography tests are the other factors that hamper the market growth during the forecast period.
This research report segmented and sub-segmented the Europe mammography market into the following categories:
Based on the product, the digital systems segment is predicted to hold a leading share of the European market during the forecast period.
The digital technology segment is estimated to witness the highest share of the European market during the forecast period.
Based on application, the screening segment accounted for the leading share of the European market during the forecast period.
The European mammography market captured the second largest share of the worldwide market in 2022 and is anticipated to grow at a notable CAGR during the forecast period owing to the growing patient count suffering from chronic diseases, rapid adoption of technological developments in the healthcare systems, and rising number of research facilities in the European counties.
Among different nations of Europe, Germany is one of the fastest-growing markets due to the gigantic productive economy, adoption of advanced technology and rising incidences of breast cancer are majorly driving the German mammography market. In 2018, around 72,000 new breast cancer cases were recorded, of which 19,000 women died. Under the mammography screening programs in Germany, women between 50- 70 can have free mammography tests every two years. German government decide to conduct this program to reduce breast cancer among the women population and helps in the early detection of cancer for the best treatment. In addition, increasing the adoption of mammography in every hospital and clinic in Germany is further propelling the German market growth.
However, the UK mammography market is estimated to record the highest growth rate during the forecast period. Breast cancer is the fourth leading cause of cancer deaths in the UK and registered 7% of cancer deaths in 2017. From 2015 to 2017, an average of 31 women passed away due to breast cancer. This rising prevalence and incidence of breast cancer in the United Kingdom is estimated to offer significant growth to the UK mammography market. A recent survey shows 2 million women have breast cancer screening in the United Kingdom. In addition, increasing postgraduate mammography courses and the number of radiologists in this country helps develop the market growth.
KEY MARKET PLAYERS:
Companies playing a promising role in the Europe mammography market profiled in this report are Fujifilm, GE Healthcare, Hologic, Metaltronica, Philips Healthcare, Planmed, Siemens Healthcare, Sonocine, and Toshiba Medical Systems.
The European mammography market was worth USD 458 million in 2022.
The growing prevalence of breast cancer in Europe, as well as the growing awareness about the importance of early detection and diagnosis of breast cancer are majorly driving the European mammography market.
Hologic, Siemens Healthineers, GE Healthcare, Fujifilm, and Philips Healthcare are some of the leading companies in the Europe mammography market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org